Brooklyn, United States
Synchron is a Brain Computer Interface startup that was founded in 2016. The company is focused on developing implantable neurotechnology to unlock the brain's potential and address unmet medical needs on a large scale. With headquarters in the United States, Synchron operates in diverse industries including IT, Information Technology, Manufacturing, Medical Devices, and Marketing.
In its latest funding round, Synchron secured a significant $75.00M Series C investment on 15 December 2022. Notably, this investment was backed by a consortium of prominent investors including Khosla Ventures, Bezos Expeditions, Green D Ventures, Moore Strategic Ventures, Subversive Capital, General Advance, METIS innovative, Alumni Ventures, Castor Ventures, and Reliance Industries.
Overall, Synchron's cutting-edge focus on brain-computer interface technology and its success in securing substantial investment from industry-leading backers position the company as a compelling player in the neurotechnology space, poised for further growth and impact in the coming years.
